Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy

BACKGROUND: Non-nucleoside reverse transcription inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART) is the recommended first-line regimen for children in Thailand. This study was aimed to assess pattern and predictors of immune recovery in antiretroviral-naive Thai children startin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thanyawee Puthanakit, Stephen J. Kerr, Jintanat Ananworanich, Torsak Bunupuradah, Pitch Boonrak, Virat Sirisanthana
Format:	Journal
Published:	2018
Subjects:	Medicine
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=67649559583&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49409
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Podjanee Jittamala, et al.
Published: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Podjanee Jittamala, et al.
Published: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Jittamala P., et al.
Published: (2014)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Thanyawee Puthanakit, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Thanyawee Puthanakit, et al.
Published: (2018)

Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014)

The effectiveness of highly active antiretroviral therapy among HIV-infected children in Asian countries
by: Torsak Bunupuradah, et al.
Published: (2018)

The effectiveness of highly active antiretroviral therapy among HIV-infected children in Asian countries
by: Torsak Bunupuradah, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014)

Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand
by: Thanyawee Puthanakit, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Puthanakit T., et al.
Published: (2014)

Recovery From Lipodystrophy in HIV-infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy
by: Aurpibul L., et al.
Published: (2014)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
by: B. Lee, et al.
Published: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
by: B. Lee, et al.
Published: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
by: David C. Boettiger, et al.
Published: (2018)

Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children
by: Thanyawee Puthanakit, et al.
Published: (2018)

Therapeutic drug monitoring of lopinavir in human immunodeficiency virus-infected children receiving adult tablets
by: Thanyawee Puthanakit, et al.
Published: (2018)

Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens
by: Torsak Bunupuradah, et al.
Published: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
by: Boettiger D., et al.
Published: (2017)

Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand
by: Puthanakit T., et al.
Published: (2014)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
by: Lee B., et al.
Published: (2014)

Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy
by: L. Aurpibul, et al.
Published: (2018)

Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)

HIV-1 Drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Somnuek Sungkanuparph, et al.
Published: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Michele W. Tang, et al.
Published: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Michele W. Tang, et al.
Published: (2018)

Initiation of antiretroviral treatment with dual nucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected infants with less advanced disease in a resource-limited setting: A Multi-Center Study in Thailand 1998-2000
by: Kulkanya Chokephaibulkit, et al.
Published: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Tang M.W., et al.
Published: (2014)

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting
by: Somnuek Sungkanuparph, et al.
Published: (2018)

Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Measles outbreak in an orphanage: HIV-Infected children on antiretroviral therapy are still at risk
by: Linda Aurpibul, et al.
Published: (2018)